New research disputes a widely publicized study that linked testosterone replacement therapy with an increased risk of cardiovascular events and all-cause mortality.
New research shows that testosterone therapy does not significantly improve erectile function or lessen mild to moderate aging male symptoms in obese patients with type 2 diabetes mellitus.
Prior studies have reached contradictory conclusions about how strongly low levels of total testosterone correlate with high levels of metabolic syndrome.
Study results indicate androgen-deprivation therapy (ADT) does not extend the lives of men with early-stage prostate cancer.
Researchers in Australia have released the results of a study showing that dropping testosterone levels in older men could potentially put them at risk when taking care of themselves in their later years.
Researchers analyzed records from more than 25,000 Medicare beneficiaries and found no evidence that testosterone replacement therapy increases the risk of heart attack among older men.